Stocks

Topics also related to Technology:

Search Stocks

Gainers & Losers

  • NYSE
  • NASDAQ
  • AMEX
  • FTSE
  • NIKKEI

Gainers

Symb Last Change Chg %
EXM.N 0.78 +0.14 +21.86
PULS.N 0.90 +0.12 +15.38
KID.N 1.50 +0.12 +8.70
CGA.N 3.52 +0.26 +7.98
GNI.N 86.29 +6.29 +7.86

Losers

Symb Last Change Chg %
GTY.N 18.16 -0.43 -2.30
ERJ.N 26.53 -0.48 -1.78
IWM.N 73.83 -0.61 -0.71
CIB.N 59.64 -0.28 -0.46
PRA.N 89.47 -0.25 -0.28
Data as of Tue Sep 25, 2012 7:30am EDT.
Source: Thomson Reuters

Hot Stocks

Google shares hit record high, find favor on Street

Photo

SAN FRANCISCO - Google Inc shares set an all-time high on Monday, with the Web giant's reliable advertising business back in vogue among Wall Street investors disenchanted with younger social media companies.

StanChart shares slip as stake sale talk resurfaces

LONDON - Standard Chartered shares fell more than 3 percent on Tuesday as speculation resurfaced that Singapore state investor Temasek may sell its 18 percent stake in the Asia-focused bank.

Questcor reveals U.S. probe of marketing, shares dive

- Questcor Pharmaceuticals Inc said it was being investigated by a U.S. agency over its promotional practices, sending its shares sliding by a third just days after Aetna cut back reimbursements for Acthar, the company's main drug.

Valeant buys Visudyne drug from QLT; QLT stock jumps

TORONTO - Valeant Pharmaceuticals International Inc said on Monday it has acquired Visudyne, a drug used to treat age-related blindness, from Canadian biotech firm QLT Inc for $112.5 million.

Facebook shares drop after Barron's snub

SAN FRANCISCO - Facebook shares dropped on Monday after financial weekly Barron's questioned the social networking company's value and priced its stock at just $15.

Peregrine says lung cancer trial data erroneous, shares sink

- Peregrine Pharmaceuticals Inc on Monday warned of discrepancies in the results of a mid-stage lung cancer trial, the second time in six months the drugmaker has got into trouble over its data, wiping off more than three-quarters of its market value.

U.S. coal company shares fall on downgrades

- Shares in U.S. coal companies, which have been buoyed recently by positive global economic news, fell on Monday after Bank of America cut the ratings for two major coal miners.

Shares slump as coal miner Bumi probes irregularities

MOSCOW/JAKARTA - Bumi Plc , the London-listed miner part-owned by Indonesia's influential Bakrie family, has launched an urgent investigation into potential financial irregularities at its subsidiaries, sending its shares down more than 30 percent.

Jefferies shares drop sharply on weak operating results

- Jefferies Group Inc , an investment bank, reported quarterly banking and trading revenue below some analysts' forecasts, a sign that the summer was likely also rough for its bigger competitors, and the bank's shares fell 6.6 percent.

Dehaier Medical wins three-year supply contract, shares up

- China-based Dehaier Medical Systems Ltd said a medical equipment manufacturer in Ukraine signed a three-year contract to buy its air compressors and customized trolleys.

Search Stocks

No related earnings announcements are currently scheduled within the next 7 days.

Symb 4 wk rating
change
Current mean
rating
APFC.OQ 3.00 to 1.00 Buy
REED.OQ 3.00 to 1.00 Buy
ABCD.OQ 2.00 to 1.00 Buy
TRR.N 4.00 to 3.00 Hold
DXYN.OQ 2.00 to 1.00 Buy
Symb 4 wk rating
change
Current mean
rating
ADAT.OQ 1.00 to 3.00 Hold
HTCO.OQ 1.00 to 3.00 Hold
AMBT.OQ 1.00 to 3.00 Hold
BZC.A 1.00 to 3.00 Hold
IRIS.OQ 1.40 to 3.20 Hold

Topics also related to Technology: